This is a multicentre randomised controlled trial evaluating global health related quality of life outcomes in patients with malignant pleural effusions. Patients will be randomised to receive either chest drain and talc pleurodesis or indwelling pleural catheter and talc pleurodesis. Patients will be followed up for 3 months post intervention
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
142
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Global health-related quality of life
Global health related quality of life as measured by EORTC QLQ-C30
Time frame: 30 days
Global health-related quality of life
Time frame: 60 and 90 days
Pleurodesis failure rate
Subsequent pleural intervention required on same side as pleurodesis Chest X-ray opacification greater than 25% on side of intervention
Time frame: 30, 60 and 90 days
Improvement in symptoms of pain and breathlessness
Medical Research Council (MRC) dyspnoea scale 100mm Visual Analog Scale for pain and breathlessness
Time frame: 30, 60 and 90 days
Complication rate
Clinical review and adverse event documentation
Time frame: Day 7, 14, 30, 60 and 90
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.